Geoffrey L. Smith | Academic Influence

Geoffrey L. Smith's AcademicInfluence.com Rankings

Geoffrey L. Smith

Biology

#2400

World Rank

#3813

Historical Rank

Virology

#59

World Rank

#62

Historical Rank

biology Degrees

Download Badge

Biology

Geoffrey L. Smith's Degrees

Bachelors Biology University of Manchester

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2025

Why Is Geoffrey L. Smith Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Geoffrey Lilley Smith FRS FMedSci FRSB is a British virologist and medical research authority in the area of Vaccinia virus and the family of Poxviruses. Since 1 October 2011 he is head of the Department of Pathology at the University of Cambridge and a principal research fellow of the Wellcome Trust. Before that, he was head of the Department of Virology at Imperial College London.

(See a Problem?)

Geoffrey L. Smith's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara (1998) (718)
Vaccinia virus: a selectable eukaryotic cloning and expression vector. (1982) (632)
General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes (1984) (624)
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans (2003) (607)
Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. (1985) (524)
Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species soecificity (1995) (513)
A soluble receptor for interleukin-1β encoded by vaccinia virus: A novel mechanism of virus modulation of the host response to infection (1992) (503)
The formation and function of extracellular enveloped vaccinia virus. (2002) (498)
A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. (2000) (490)
Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. (2008) (446)
Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype (1985) (442)
The Poxvirus Protein A52R Targets Toll-like Receptor Signaling Complexes to Suppress Host Defense (2003) (392)
Vaccinia virus protein A46R targets multiple Toll-like–interleukin-1 receptor adaptors and contributes to virulence (2005) (390)
Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen (1983) (384)
Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine. (1998) (360)
Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen (1988) (359)
Poxvirus genomes: a phylogenetic analysis. (2004) (357)
Effective Induction of Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes in Macaques by Using a Multiepitope Gene and DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccination Regimen (1999) (346)
DNA-PK is a DNA sensor for IRF-3-dependent innate immunity (2012) (339)
Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity (1995) (304)
Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA. (1983) (298)
Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity. (2013) (298)
Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. (1998) (279)
Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes (1987) (272)
Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters. (1983) (268)
The Vaccinia Virus Soluble Alpha/Beta Interferon (IFN) Receptor Binds to the Cell Surface and Protects Cells from the Antiviral Effects of IFN (2000) (265)
A complex between the MHC class I homologue encoded by human cytomegalovirus and β2 microglobulin (1990) (261)
Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein. (1987) (260)
Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses (1988) (259)
Vaccinia virus expression vectors. (1986) (254)
Live recombinant vaccinia virus protects chimpanzees against hepatitis B (1984) (254)
Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. (1998) (252)
Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime. (1998) (237)
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS) (2017) (228)
Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus. (1994) (220)
Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1beta-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1beta-induced fever. (1997) (219)
Vaccinia virus utilizes microtubules for movement to the cell surface (2001) (216)
A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. (1992) (216)
Vaccinia virus morphogenesis and dissemination. (2008) (215)
Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells (1984) (212)
Vaccinia virus immune evasion. (1999) (210)
The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. (1993) (205)
Inhibition of biological activity of multiplication-stimulating activity by binding to its carrier protein. (1980) (203)
Repulsion of Superinfecting Virions: A Mechanism for Rapid Virus Spread (2010) (188)
EGTA purity and the buffering of calcium ions in physiological solutions. (1984) (186)
Intracellular and extracellular vaccinia virions enter cells by different mechanisms. (1998) (182)
Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses. (1987) (180)
Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein (2007) (179)
Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans. (2005) (176)
Genome Sequence Diversity and Clues to the Evolution of Variola (Smallpox) Virus (2006) (174)
Inhibition of IκB Kinase by Vaccinia Virus Virulence Factor B14 (2008) (170)
Nucleotide sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repeat. (1991) (167)
Identification and expression of a human cytomegalovirus glycoprotein with homology to the Epstein-Barr virus BXLF2 product, varicella-zoster virus gpIII, and herpes simplex virus type 1 glycoprotein H (1988) (167)
17th Century Variola Virus Reveals the Recent History of Smallpox (2016) (163)
The sequence of camelpox virus shows it is most closely related to variola virus, the cause of smallpox. (2002) (161)
Vaccinia Virus Proteins A52 and B14 Share a Bcl-2–Like Fold but Have Evolved to Inhibit NF-κB rather than Apoptosis (2008) (161)
Vaccinia Virus Intracellular Mature Virions Contain only One Lipid Membrane (1999) (156)
Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes. (1999) (156)
A mechanism for the inhibition of fever by a virus. (1996) (154)
Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress (1992) (153)
Vaccinia Virus Protein C6 Is a Virulence Factor that Binds TBK-1 Adaptor Proteins and Inhibits Activation of IRF3 and IRF7 (2011) (151)
Endocytic tubules regulated by Rab GTPases 5 and 11 are used for envelopment of herpes simplex virus (2012) (149)
Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus (1996) (149)
Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. (1986) (147)
Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes. (2002) (145)
The exit of vaccinia virus from infected cells. (2004) (140)
The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particles. (2000) (137)
Potentiometric measurements of stoichiometric and apparent affinity constants of EGTA for protons and divalent ions including calcium. (1985) (133)
Vaccinia virus homologues of the Shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumor necrosis factor receptor family. (1991) (133)
IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress. (1990) (133)
The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. (2002) (132)
Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors. (1999) (132)
Ligand-induced and nonfusogenic dissolution of a viral membrane. (2006) (132)
Vaccinia virus encodes a family of genes with homology to serine proteinase inhibitors. (1989) (132)
Cytokine receptors encoded by poxviruses: a lesson in cytokine biology. (1995) (131)
Interactions between Vaccinia Virus IEV Membrane Proteins and Their Roles in IEV Assembly and Actin Tail Formation (1999) (131)
The genome sequence of Yaba-like disease virus, a yatapoxvirus. (2001) (130)
Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination (2006) (129)
Rapid method for the purification of DNA from subgingival microorganisms. (1989) (127)
Anti-influenza virus cytotoxic T lymphocytes recognize the three viral polymerases and a nonstructural protein: responsiveness to individual viral antigens is major histocompatibility complex controlled (1987) (126)
Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion. (1998) (123)
Vaccinia virus cores are transported on microtubules. (2003) (122)
A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae. (1999) (120)
A novel virus binding assay using confocal microscopy: demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors (1997) (118)
Replication of the influenza virus genome. (1982) (118)
Virus strategies for evasion of the host response to infection. (1994) (117)
Vaccinia Virus Interleukin-18-Binding Protein Promotes Virulence by Reducing Gamma Interferon Production and Natural Killer and T-Cell Activity (2003) (117)
Two vaccinia virus proteins structurally related to the interleukin-1 receptor and the immunoglobulin superfamily. (1991) (116)
Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. (2005) (114)
Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime. (1999) (114)
A New Inhibitor of Apoptosis from Vaccinia Virus and Eukaryotes (2007) (111)
The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles. (2000) (108)
Vaccinia virus motility. (2003) (108)
Vaccinia virus serpins B13R (SPI-2) and B22R (SPI-1) encode M(r) 38.5 and 40K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model. (1995) (107)
Identification of Human Herpesvirus 8-Specific Cytotoxic T-Cell Responses (1999) (106)
Vaccinia Virus F12L Protein Is Required for Actin Tail Formation, Normal Plaque Size, and Virulence (2000) (105)
A Mechanism for the Inhibition of DNA-PK-Mediated DNA Sensing by a Virus (2013) (104)
Vaccinia virus gene B1R encodes a 34-kDa serine/threonine protein kinase that localizes in cytoplasmic factories and is packaged into virions. (1992) (103)
Poxvirus Targeting of E3 Ligase β-TrCP by Molecular Mimicry: A Mechanism to Inhibit NF-κB Activation and Promote Immune Evasion and Virulence (2013) (101)
Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation. (1997) (98)
Antibody neutralization of the extracellular enveloped form of vaccinia virus. (2001) (97)
Numerical Analysis Of Total Fatty Acid Profiles In The Identification Of Coryneform, Nocardioform And Some Other Bacteria (1983) (95)
Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I‐restricted epitope with recombinant carriers suitable for human use (1998) (93)
A study of the vaccinia virus interferon-γ receptor and its contribution to virus virulence (2002) (93)
Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy. (2006) (93)
Plasmodium knowlesi sporozoite antigen: expression by infectious recombinant vaccinia virus. (1984) (92)
The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface. (2002) (92)
Hepatitis B virus large surface protein is not secreted but is immunogenic when selectively expressed by recombinant vaccinia virus (1986) (91)
Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice. (1998) (89)
Diverse variola virus (smallpox) strains were widespread in northern Europe in the Viking Age (2020) (88)
Inhibition of Apoptosis and NF-κB Activation by Vaccinia Protein N1 Occur via Distinct Binding Surfaces and Make Different Contributions to Virulence (2011) (88)
Vaccinia virus immune evasion (1997) (87)
Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: role of the A33R protein in antibody-resistant spread. (2002) (87)
Virus-Induced Cell Motility (1998) (85)
Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence. (2002) (85)
Human immunodeficiency virus co-infection increases placental parasite density and transplacental malaria transmission in Western Kenya. (2009) (84)
A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection. (2003) (83)
The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model. (2002) (82)
The vaccinia virus A41L protein is a soluble 30 kDa glycoprotein that affects virus virulence. (2001) (81)
Vaccinia virus glycoproteins and immune evasion. The sixteenth Fleming Lecture. (1993) (80)
Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus. (1990) (80)
Nucleotide sequence of 21.8 kbp of variola major virus strain Harvey and comparison with vaccinia virus. (1992) (80)
The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice. (2011) (79)
Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes (1986) (78)
Steroid Hormone Synthesis by Vaccinia Virus Suppresses the Inflammatory Response to Infection (2003) (78)
Influenza virus-like particles as pandemic vaccines. (2009) (78)
A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees. (2001) (78)
The Extracellular Domain of Vaccinia Virus Protein B5R Affects Plaque Phenotype, Extracellular Enveloped Virus Release, and Intracellular Actin Tail Formation (1998) (77)
Structure and Function of A41, a Vaccinia Virus Chemokine Binding Protein (2008) (76)
How vaccinia virus has evolved to subvert the host immune response (2011) (74)
Virus proteins that bind cytokines, chemokines or interferons. (1996) (73)
Extracellular enveloped vaccinia virus. Entry, egress, and evasion. (1998) (72)
A vaccinia serine protease inhibitor which prevents virus-induced cell fusion. (1992) (71)
Viruses, Plagues, and History (1998) (71)
Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence (2013) (71)
Nucleotide sequence of a 55 kbp region from the right end of the genome of a pathogenic African swine fever virus isolate (Malawi LIL20/1). (1994) (71)
Vaccinia virus encodes an active thymidylate kinase that complements a cdc8 mutant of Saccharomyces cerevisiae. (1991) (70)
Vaccinia virus strain Western Reserve protein B14 is an intracellular virulence factor. (2006) (70)
Inducible gene expression from vaccinia virus vectors. (1990) (68)
Poxviruses: Interfering with Interferon (1998) (68)
B and CTL responses to the ALK protein in patients with ALK‐positive ALCL (2006) (66)
Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy. (2005) (66)
The PA influenza virus polymerase subunit is a phosphorylated protein. (1998) (65)
An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model. (2005) (64)
Vaccinia virus encodes a thymidylate kinase gene: sequence and transcriptional mapping. (1989) (62)
Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus (2007) (62)
A mechanism for induction of a hypoxic response by vaccinia virus (2013) (61)
Enumeration of subgingival species on primary isolation plates using colony lifts. (1992) (61)
A Soluble Chemokine-Binding Protein from Vaccinia Virus Reduces Virus Virulence and the Inflammatory Response to Infection1 (2003) (61)
hGAAP promotes cell adhesion and migration via the stimulation of store-operated Ca2+ entry and calpain 2 (2013) (59)
Anchoring a secreted plasmodium antigen on the surface of recombinant vaccinia virus-infected cells increases its immunogenicity (1986) (59)
The vaccinia virus kelch-like protein C2L affects calcium-independent adhesion to the extracellular matrix and inflammation in a murine intradermal model. (2003) (59)
Inhibition of the RNA polymerase III-mediated dsDNA-sensing pathway of innate immunity by vaccinia virus protein E3 (2010) (59)
An investigation of incorporation of cellular antigens into vaccinia virus particles. (2002) (59)
An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease (2021) (58)
Transcriptional mapping and nucleotide sequence of a vaccinia virus gene encoding a polypeptide with extensive homology to DNA ligases. (1989) (58)
Induction of protective immunity with antibody to herpes simplex virus type 1 glycoprotein H (gH) and analysis of the immune response to gH expressed in recombinant vaccinia virus. (1991) (56)
Vaccinia Virus Protein C6 Inhibits Type I IFN Signalling in the Nucleus and Binds to the Transactivation Domain of STAT2 (2016) (56)
Ecgonine methyl ester, a major metabolite of cocaine. (1982) (55)
The Vaccinia Virus Superoxide Dismutase-Like Protein (A45R) Is a Virion Component That Is Nonessential for Virus Replication (2001) (54)
Rumen ciliated protozoa decrease generation time and adjust 18S ribosomal DNA copies to adapt to decreased transfer interval, starvation, and monensin. (2009) (54)
Overexpression of the vaccinia virus A38L integral membrane protein promotes Ca2+ influx into infected cells (1996) (54)
Vaccinia Virus Protein A49 Is an Unexpected Member of the B-cell Lymphoma (Bcl)-2 Protein Family* (2015) (53)
Vaccinia virus protein C4 inhibits NF-κB activation and promotes virus virulence (2012) (53)
Vaccinia virus encodes a polypeptide with DNA ligase activity. (1989) (53)
Six-transmembrane Topology for Golgi Anti-apoptotic Protein (GAAP) and Bax Inhibitor 1 (BI-1) Provides Model for the Transmembrane Bax Inhibitor-containing Motif (TMBIM) Family* (2012) (52)
A study of the vaccinia virus interferon-gamma receptor and its contribution to virus virulence. (2002) (51)
Poxviruses: Capturing Cytokines and Chemokines (1998) (51)
Vaccinia virus DNA ligase is nonessential for virus replication: recovery of plasmids from virus-infected cells. (1991) (50)
The vaccinia virus soluble interferon-gamma receptor is a homodimer. (2002) (50)
Vaccinia virus semaphorin A39R is a 50-55 kDa secreted glycoprotein that affects the outcome of infection in a murine intradermal model. (2001) (49)
Structure of CrmE, a virus-encoded tumour necrosis factor receptor. (2007) (49)
Vaccinia virus intracellular enveloped virions move to the cell periphery on microtubules in the absence of the A36R protein. (2005) (48)
Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence (2008) (48)
Poxviruses (2020) (47)
The vaccinia virus A4OR gene product is a nonstructural, type II membrane glycoprotein that is expressed at the cell surface. (1999) (47)
Malaria-Induced Murine Pregnancy Failure: Distinct Roles for IFN-γ and TNF12 (2009) (46)
Mapping the IκB Kinase β (IKKβ)-binding Interface of the B14 Protein, a Vaccinia Virus Inhibitor of IKKβ-mediated Activation of Nuclear Factor κB* (2011) (46)
Increased antibody responses to human papillomavirus type 16 L1 protein expressed by recombinant vaccinia virus lacking serine protease inhibitor genes. (1990) (46)
Vaccinia Protein F12 Has Structural Similarity to Kinesin Light Chain and Contains a Motor Binding Motif Required for Virion Export (2010) (44)
Microbe-vector interactions in vector-borne diseases. (2004) (43)
How Does Vaccinia Virus Interfere With Interferon? (2018) (43)
Vaccinia virus evasion of regulated cell death. (2017) (43)
Vaccinia virus protein K7 is a virulence factor that alters the acute immune response to infection (2013) (43)
Two early vaccinia virus genes encode polypeptides related to protein kinases. (1989) (42)
Purification and characterization of multiplication-stimulating activity (MSA) carrier protein. (1981) (42)
A 46 R and A 52 R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling (2000) (42)
Intradermal immune response after infection with Vaccinia virus. (2006) (41)
Vaccinia virus lacking the Bcl-2-like protein N1 induces a stronger natural killer cell response to infection (2008) (41)
Histone deacetylase 4 promotes type I interferon signaling, restricts DNA viruses, and is degraded via vaccinia virus protein C6 (2019) (41)
Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax (2008) (41)
Gamma Interferon-Induced Interferon Regulatory Factor 1-Dependent Antiviral Response Inhibits Vaccinia Virus Replication in Mouse but Not Human Fibroblasts (2009) (41)
Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory (2018) (41)
Receptors for gamma-interferon encoded by poxviruses: implications for the unknown origin of vaccinia virus. (1996) (40)
Maternal Malaria Induces a Procoagulant and Antifibrinolytic State That Is Embryotoxic but Responsive to Anticoagulant Therapy (2012) (40)
Quantitative Temporal Proteomic Analysis of Vaccinia Virus Infection Reveals Regulation of Histone Deacetylases by an Interferon Antagonist (2019) (40)
Vaccinia virus kelch protein A55 is a 64 kDa intracellular factor that affects virus-induced cytopathic effect and the outcome of infection in a murine intradermal model. (2006) (40)
Expression of a single pair of desmosomal glycoproteins renders the corneal epithelium unique amongst stratified epithelia. (2000) (39)
Expression and characterization of herpes simplex virus type 1 (HSV-1) glycoprotein G (gG) by recombinant vaccinia virus: neutralization of HSV-1 infectivity with anti-gG antibody. (1987) (39)
Expression of the infectious bronchitis virus spike protein by recombinant vaccinia virus and induction of neutralizing antibodies in vaccinated mice. (1987) (39)
The vaccinia virus A38L gene product is a 33-kDa integral membrane glycoprotein. (1995) (38)
DNA-PK Is Targeted by Multiple Vaccinia Virus Proteins to Inhibit DNA Sensing (2018) (38)
Vaccinia Virus Inhibits NF-κB-Dependent Gene Expression Downstream of p65 Translocation (2013) (38)
Vaccinia virus gene F3L encodes an intracellular protein that affects the innate immune response (2007) (37)
A role for vaccinia virus protein C16 in reprogramming cellular energy metabolism (2015) (36)
Phosphorylation of ribosomal proteins by the vaccinia virus B1R protein kinase (1993) (36)
Soluble interferon-γ receptors encoded by poxviruses (1996) (36)
Duplicated genes within the variable right end of the genome of a pathogenic isolate of African swine fever virus. (1993) (35)
Camelpox virus encodes a schlafen-like protein that affects orthopoxvirus virulence (2007) (35)
Analysis of an Interaction between the Soluble Vaccinia Virus-Coded Type I Interferon (IFN)-Receptor and Human IFN-α1 and IFN-α2 (1997) (35)
Characterization of Analytical Reference Glass-1 (ARG-1) (1993) (34)
Analysis of the L1 gene product of human papillomavirus type 16 by expression in a vaccinia virus recombinant. (1988) (34)
A mutational analysis of the vaccinia virus B5R protein. (2001) (34)
Deletion of immunomodulator C6 from vaccinia virus strain Western Reserve enhances virus immunogenicity and vaccine efficacy (2013) (34)
Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane (2009) (34)
Vaccinia virus core protein VP8 is required for virus infectivity, but not for core protein processing or for INV and EEV formation. (1994) (34)
Vaccinia virus gene B7R encodes an 18-kDa protein that is resident in the endoplasmic reticulum and affects virus virulence. (2000) (34)
Transient Inhibition of Polyoma Virus Synthesis by Sendai Virus (Parainfluenza I) I. Demonstration and Nature of the Inhibition by Inactivated Virus (1972) (33)
African swine fever virus gene j13L encodes a 25-27 kDa virion protein with variable numbers of amino acid repeats. (1995) (33)
African swine fever virus encodes a serine protein kinase which is packaged into virions (1993) (33)
Golgi anti-apoptotic protein: a tale of camels, calcium, channels and cancer (2017) (33)
Increased ouabain-sensitive 86Rubidium uptake after mitogenic stimulation of quiescent chicken embryo fibroblasts with purified multiplication-stimulating activity (1977) (32)
Replacing the SCR domains of vaccinia virus protein B5R with EGFP causes a reduction in plaque size and actin tail formation but enveloped virions are still transported to the cell surface. (2002) (31)
Vaccinia virion protein I8R has both DNA and RNA helicase activities: implications for vaccinia virus transcription (1996) (31)
Bacterial cell membranes. I. Reaggregation of membrane subunits from Micrococcus lysodeikticus. (1967) (30)
Human and Viral Golgi Anti-apoptotic Proteins (GAAPs) Oligomerize via Different Mechanisms and Monomeric GAAP Inhibits Apoptosis and Modulates Calcium* (2013) (30)
A new member of the interleukin 10-related cytokine family encoded by a poxvirus. (2004) (30)
microbe–vector interactions in vector-borne diseases: How do mosquito vectors live with their viruses? (2004) (30)
Vaccinia virions lacking core protein VP8 are deficient in early transcription (1996) (29)
Recombinant vaccinia viruses as new live vaccines. (1984) (28)
Induction of CD8+ T‐lymphocyte responses to a secreted antigen of Mycobacterium tuberculosis by an attenuated vaccinia virus (2001) (28)
Methods for the isolation, culture and characterisation of equine pulmonary artery endothelial cells. (1997) (28)
Golgi Anti-apoptotic Proteins Are Highly Conserved Ion Channels That Affect Apoptosis and Cell Migration* (2015) (28)
An African swine fever virus gene with homology to DNA ligases. (1992) (28)
Vaccinia virus-encoded cytokine receptor binds and neutralizes chicken interferon-gamma. (1998) (27)
Nuclear and nucleolar localization of an African swine fever virus protein, I14L, that is similar to the herpes simplex virus-encoded virulence factor ICP34.5. (1999) (27)
Intracellular sensing of viral DNA by the innate immune system. (2014) (26)
Inhibition of Translation Initiation by Protein 169: A Vaccinia Virus Strategy to Suppress Innate and Adaptive Immunity and Alter Virus Virulence (2015) (26)
Analysis of the anti-apoptotic activity of four vaccinia virus proteins demonstrates that B13 is the most potent inhibitor in isolation and during viral infection (2014) (26)
Genus Orthopoxvirus: Vaccinia virus (2007) (26)
Protein B5 is required on extracellular enveloped vaccinia virus for repulsion of superinfecting virions (2012) (26)
Studying the binding and entry of the intracellular and extracellular enveloped forms of vaccinia virus. (2004) (25)
Vaccinia Virus BBK E3 Ligase Adaptor A55 Targets Importin-Dependent NF-κB Activation and Inhibits CD8+ T-Cell Memory (2019) (25)
Entry, Egress, and Evasion (1998) (25)
Immune modulation by proteins secreted from cells infected by vaccinia virus. (1999) (25)
The herpes simplex virus type 1 US7 gene product is a 66K glycoprotein and is a target for complement-dependent virus neutralization. (1988) (24)
Smallpox in the Post-Eradication Era (2020) (24)
Enhancement of CD8+ T-cell memory by removal of a vaccinia virus nuclear factor-κB inhibitor (2015) (24)
Vaccinia Virus Induces Ca2+-Independent Cell-Matrix Adhesion during the Motile Phase of Infection (1998) (24)
Vaccinia virion protein VP8, the 25 kDa product of the L4R gene, binds single-stranded DNA and RNA with similar affinity. (1997) (23)
Characterization of vaccinia virus gene B12R. (1993) (23)
Comparison of two methods for the small-scale extraction of DNA from subgingival microorganisms. (1989) (22)
Identification of somatomedin-like polypeptides produced by mammary tumors of BALB/c mice. (1980) (22)
Vaccinia Virus Protein Complex F12/E2 Interacts with Kinesin Light Chain Isoform 2 to Engage the Kinesin-1 Motor Complex (2015) (22)
Soluble interferon-gamma receptors encoded by poxviruses. (1996) (21)
Serological responses in humans to the smallpox vaccine LC16m8 (2011) (21)
The use of semi-automatic pipettes in the viable counting of bacteria. (1973) (21)
The African Swine Fever Virus Protein j4R Binds to the Alpha Chain of Nascent Polypeptide-Associated Complex (2002) (21)
African swine fever virus encodes a gene with extensive homology to type II DNA topoisomerases. (1992) (21)
Differential processing and presentation of the H-2D(b)-restricted epitope from two different strains of influenza virus nucleoprotein. (2001) (20)
Multiple Bcl-2 family immunomodulators from vaccinia virus regulate MAPK/AP-1 activation (2016) (20)
Vaccinia virus virulence factor N1 can be ubiquitylated on multiple lysine residues (2014) (20)
Vaccinia virus serpins B13R and B22R do not inhibit antigen presentation to class I-restricted cytotoxic T lymphocytes. (1995) (20)
Non-isotopic DNA probes for the identification of subgingival microorganisms. (1989) (19)
Use of vaccinia virus as an infectious molecular cloning and expression vector. (1983) (19)
Caspases in Virus-Infected Cells Contribute to Recognition by CD8+ T Lymphocytes (2010) (18)
The Freshwater Crayfishes of Australia (2009) (18)
Vaccinia virus: a selectable eukaryotic cloning and expression vector. 1982. (1992) (18)
Deletion of fowlpox virus homologues of vaccinia virus genes between the 3 beta-hydroxysteroid dehydrogenase (A44L) and DNA ligase (A50R) genes. (1994) (18)
Bacterial cell membranes. II. Possible structure of the basal membrane continuum of Micrococcus lysodeikticus. (1967) (17)
NF-κB activation is a turn on for vaccinia virus phosphoprotein A49 to turn off NF-κB activation (2019) (17)
Increased attenuation but decreased immunogenicity by deletion of multiple vaccinia virus immunomodulators (2016) (17)
Vaccinia virus protein A49 activates Wnt signalling by targetting the E3 ligase β-TrCP (2017) (17)
Vaccinia virus: an expression vector for genes from parasites (1986) (16)
Structure/Function Relationships of CCR8 Agonists and Antagonists (2006) (16)
Yaba-like disease virus protein Y144R, a member of the complement control protein family, is present on enveloped virions that are associated with virus-induced actin tails. (2004) (15)
The origins and genomic diversity of American Civil War Era smallpox vaccine strains (2020) (15)
Yaba-like disease virus protein 7L is a cell-surface receptor for chemokine CCL1. (2003) (15)
Three African swine fever virus genes encoding proteins with homology to putative helicases of vaccinia virus. (1993) (14)
The effects of targeting the vaccinia virus B5R protein to the endoplasmic reticulum on virus morphogenesis and dissemination. (1999) (13)
Mutagenic repair of double-stranded DNA breaks in vaccinia virus genomes requires cellular DNA ligase IV activity in the cytosol. (2018) (13)
Analysis of an interaction between the soluble vaccinia virus-coded type I interferon (IFN)-receptor and human IFN-alpha1 and IFN-alpha2. (1997) (13)
Configuration 4f 6 ( 7 F)5d6s 2 in Eu i (1970) (13)
Steroid hormone synthesis by a vaccinia enzyme: a new type of virus virulence factor. (1992) (13)
Vaccinia virus B5 protein affects the glycosylation, localization and stability of the A34 protein (2010) (13)
Mutations in modified virus Ankara protein 183 render it a non-functional counterpart of B14, an inhibitor of nuclear factor κB activation (2010) (13)
Corrigendum to “European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)” [Redox Biol. 13 (2017) 94–162] (2017) (12)
"Reverse" DNA hybridization method for the rapid identification of subgingival microorganisms. (1989) (12)
Synergistic Action of Bacterial Lipopolysaccharides on Serum-Stimulated DNA Synthesis in Mouse Embryo Fibroblasts (1976) (12)
Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro. (2000) (12)
Cell motility and cell morphology: How some viruses take control (1999) (12)
Identification of the viral molecules recognised by influenza specific human cytoxic T lymphocytes. (1987) (12)
Molecular mimicry of NF-κB by vaccinia virus protein enables selective inhibition of antiviral responses (2021) (12)
The vaccinia virus B9R protein is a 6 kDa intracellular protein that is non-essential for virus replication and virulence. (2002) (11)
Polyamines and the stimulation of DNA synthesis in chicken embryo fibroblasts by purified multiplication-stimulating activity. (1978) (11)
An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease (2021) (11)
RNA-based immunity in insects. (2004) (10)
Peptide immunization can elicit malaria protein-specific memory helper but not proliferative T cells. (1990) (10)
Experimental test of surface nucleated crystal growth model in lithium diborate glass (1994) (9)
Vaccinia virus vectors for gene expression. (1991) (9)
microbe–vector interactions in vector-borne diseases: Specificity of Borrelia –tick vector relationships (2004) (9)
Cell Division in a Species of Erwinia IX. Electron Microscopy of Normally Dividing Cells (1965) (9)
Stimulation of cell invasion by the Golgi Ion Channel GAAP/TMBIM4 via an H2O2-Dependent Mechanism (2019) (9)
[33] Using confocal microscopy to study virus binding and entry into cells (1999) (9)
Microbe-vector interactions in vector-borne diseases : Sixty-third Symposium of the Society for General Microbiology held at the University of Bath, March 2004 (2004) (9)
Purification of multiplication-stimulating activity carrier protein. (1987) (9)
Yaba-like disease virus chemokine receptor 7L, a CCR8 orthologue. (2006) (9)
Recombinant vaccinia viruses as live vaccines. (1987) (9)
Molecular basis of cullin-3 (Cul3) ubiquitin ligase subversion by vaccinia virus protein A55 (2019) (9)
microbe–vector interactions in vector-borne diseases: Environmental influences on arbovirus infections and vectors (2004) (9)
Cell division in a species of Erwinia. X. Morphology of the nuclear body in filaments produced by growth in the presence of D-serine. (1968) (8)
Vaccinia virus proteins A36 and F12/E2 show strong preferences for different kinesin light chain isoforms (2017) (8)
Ligation of double-stranded and single-stranded [oligo(dT)] DNA by vaccinia virus DNA ligase. (1996) (8)
The vaccinia virus soluble interferon-γ receptor is a homodimer (8)
Comment on the paper by Shchelkunov et al. (1993) FEBS Letters 319, 80‐83. Two genes encoding poxvirus cytokine receptors are disrupted or deleted in variola virus (1993) (8)
Use of recombinant vaccinia viruses to examine cytotoxic T lymphocyte recognition of individual viral proteins. (1988) (7)
Uses of vaccinia virus as a vector for the production of live recombinant vaccines (1984) (7)
A comparison of the effect of molluscum contagiosum virus MC159 and MC160 proteins on vaccinia virus virulence in intranasal and intradermal infection routes. (2018) (7)
Vaccinia virus gene SalF5R is non-essential for virus replication in vitro and in vivo. (1992) (7)
Configuration Interaction and Discovery of a Missing Term in Neutral Europium (1970) (7)
Transport and stability of the vaccinia virus A34 protein is affected by the A33 protein (2013) (7)
Vaccinia virus egress mediated by virus protein A36 is reliant on the F12 protein (2017) (7)
Analysis of EDTA-soluble cell surface components of gram-positive anaerobic cocci. (1986) (6)
African swine fever virus genome content and variability. (1993) (6)
microbe–vector interactions in vector-borne diseases: Insect transmission of viruses (2004) (6)
Survival of gram positive anaerobic cocci on swabs and their isolation from the mouth and vagina. (1986) (6)
Novel Role for ESCRT-III Component CHMP4C in the Integrity of the Endocytic Network Utilized for Herpes Simplex Virus Envelopment (2020) (6)
Enhanced Efficacy of Vaccination With Vaccinia Virus in Old vs. Young Mice (2019) (6)
Stimulation of vaccinia virion DNA helicase I8R, but not A18R, by a vaccinia core protein L4R, an ssDNA binding protein. (1996) (6)
Expression of African swine fever virus envelope protein j13L inhibits vaccinia virus morphogenesis. (1998) (6)
Cell division in a species of Erwinia. 8. Amino acid composition of the mucopeptide in dividing and non-dividing cells. (1965) (6)
Vaccinia Virus Protein C6: A Multifunctional Interferon Antagonist. (2018) (5)
Immunochemical characterization of the cell surface carbohydrate antigens of Peptostreptococcus anaerobius. (1986) (5)
Inflammatory Response to Infection Vaccinia Virus Reduces Virus Virulence and A Soluble Chemokine-Binding Protein from (2003) (5)
Odd Configurations of Neutral Titanium (Ti i) (1969) (5)
Pathogenic strategies of Anaplasma phagocytophilum, a unique bacterium that colonizes neutrophils. (2004) (5)
The crystal structure of vaccinia virus protein E2 and perspectives on the prediction of novel viral protein folds (2021) (5)
Leaky scanning translation generates a second A49 protein that contributes to vaccinia virus virulence (2020) (5)
Erratum: Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals (Journal of Clinical Investigation (2008) 118, 10, (3478-3490) doi:10.1172/JCI32460) (2012) (5)
Recombinant vaccinia virus vaccines (1989) (5)
Notes on transient host range selection for engineering vaccinia virus strain MVA. (2002) (5)
The actin nucleator Spir-1 is a virus restriction factor that promotes innate immune signalling (2022) (5)
Smallpox vaccination induces a substantial increase in commensal skin bacteria that promote pathology and influence the host response (2022) (3)
A strategy to suppress STAT1 signalling conserved in pathogenic poxviruses and paramyxoviruses (2021) (3)
microbe–vector interactions in vector-borne diseases: Evolution of tick-borne disease systems (2004) (3)
Tagging of the vaccinia virus protein F13 with mCherry causes aberrant virion morphogenesis (2017) (3)
Future vaccines for HIV (1996) (3)
The prevalence of hepatitis B serological markers in dental personnel. (1986) (3)
Author response: DNA-PK is a DNA sensor for IRF-3-dependent innate immunity (2012) (3)
Transient Inhibition of Polyoma Virus Synthesis by Sendai Virus (Parainfluenza I) II. Mechanism of the Interference by Inactivated Virus (1972) (3)
Serum stimulated DNA synthesis in mouse embryo fibroblasts. Synergistic enhancement by staphylococcal lipoteichoic acid. (1978) (3)
Poxviruses and paramyxoviruses use a conserved mechanism of STAT1 antagonism to inhibit interferon signaling (2022) (3)
Manipulation of innate immune signaling pathways by SARS-CoV-2 non-structural proteins (2022) (2)
Enhancement of CD 8 + T-cell memory by removal of a vaccinia virus nuclear factor-j B inhibitor (2015) (2)
DDX50 Is a Viral Restriction Factor That Enhances IRF3 Activation (2022) (2)
Encyclopedia of Virology (2008) (2)
Rapid spreading and immune evasion by vaccinia virus. (2014) (2)
SMALLPOX AND MONKEYPOX VIRUSES (POXVIRIDAE) (1999) (2)
Selective modulation of cell surface proteins during vaccinia infection: A resource for identifying viral immune evasion strategies (2022) (2)
Spir-1 promotes IRF3 activation and is targetted by vaccinia virus protein K7 (2020) (2)
Product consistency testing of three reference glasses in stainless steel and perfluoroalkoxy resin vessels (1995) (2)
Dysregulation of Cellular VRK1, BAF, and Innate Immune Signaling by the Vaccinia Virus B12 Pseudokinase (2022) (2)
Assessing the Spectrum of Biological Risks (2010) (2)
for Rapid Virus Spread Repulsion of Superinfecting Virions : A Mechanism (2010) (1)
Human GAAP modulates intracellular calcium fluxes (2009) (1)
Simultaneous hybridization and subsequent colour detection of subgingival bacterial DNA on colony lifts. (1993) (1)
Molecular basis of Cul3 ubiquitin ligase subversion by vaccinia virus protein A55 (2018) (1)
B1R: B1R protein kinase (vaccinia virus) (1995) (1)
Temporal analysis of the plasma membrane proteome after vaccinia virus infection sheds light on virus strategies to evade the immune response (2020) (1)
Enhanced efficacy of vaccination with vaccinia virus in old versus young mice (2019) (1)
microbe–vector interactions in vector-borne diseases: Wolbachia host–symbiont interactions (2004) (1)
Expression of Hepatitis B Virus Surface Antigens Containing Pre-s Regions by Recombinant Vaccinia Viruses (1988) (1)
Chemokine Binding Protein from Vaccinia Virus Blockade of Chemokine Activity by a Soluble (1998) (1)
Vaccines targeting vectors. (2004) (1)
Enhancement of CD8+ T-cell memory by removal of a vaccinia virus NF-κB inhibitor (2014) (1)
Recombinant Vaccinia Viruses: New Applications of an Old Vaccine (1988) (0)
Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters ( hybrid vaccinia virus / chimeric gene / live virus vaccine / recombinant DNA ) (0)
Host-Range Determinants of Poxviruses: Anticipating the Next Smallpox (2016) (0)
Heteroepitaxial growth of InP and GaInAs on GaAs substrates using nonhydride sources (1991) (0)
Transcriptional reprogramming of natural killer cells by vaccinia virus shows both distinct and conserved features with mCMV (2022) (0)
Histone deacetylase 4 promotes type I interferon signaling, restricts DNA virus replication and is 1 degraded via vaccinia virus protein C6 2 (2019) (0)
Structure of N-terminally truncated A49 from Vaccinia Virus Western Reserve (2015) (0)
Vaccinia virus entry and exit. (2000) (0)
Viral mimicry of p65/RelA transactivation domain to inhibit NF-κB activation (2020) (0)
Methods and reagents for production of a CD8 + T cell immune response (1998) (0)
Seeing space: friends, clients, and colleagues remember Robert N. Royston (1918-2008), a pioneering modernist whose teaching and work helped to define landscape architecture in postwar California (2009) (0)
Vaccinia Virus as a Carrier of Vaccine Antigens (2017) (0)
DNA- and MVA-based multi-CTL epitope vaccines for HIV and Plasmodium falciparum: Immunogenicity in mice and macaques (1997) (0)
Protein 169 inhibits protein expression after activation of several innate immune signaling pathways. (2015) (0)
The origins and genomic diversity of American Civil War Era smallpox vaccine strains (2020) (0)
Suppression of innate immunity by the vaccinia virus protein N1 promotes skin microbiota expansion and increased immune infiltration following vaccination. (2022) (0)
Short Communication Vaccinia virus gene F3L encodes an intracellular protein that affects the innate immune response (2007) (0)
Benchmar k Notes on Transient Host Range Selection fo r Engineering Vaccinia Virus Strain MVA (2002) (0)
Inhibition of IFN-gamma signalling by vaccinia virus protein C6: a multi-functional interferon antagonist (2019) (0)
Protection from Plasmodium berghei infection by priming to a single CTL epitope with vaccine carriers that do not require adjuvants (1997) (0)
Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccination (2023) (0)
The human Golgi anti-apoptotic protein induces cell invasion by an H2O2-dependent mechanism (2018) (0)
Selective modulation of cell surface proteins during vaccinia infection: implications for immune evasion strategies (2021) (0)
The inhibition of polyoma virus synthesis by 5-fluoro-deoxyuridine and reversal with 5-methyldeoxycytidine. (1977) (0)
The structure of Vaccinia virus A41 (2007) (0)
Steam venting capacity from reactor moderator (1978) (0)
Polypeptide(s) from mammary tumors of balb/c mice. Abstr. (1980) (0)
Expression of Foreign Proteins by Vaccinia Virus (1990) (0)
Construction andcharacterization ofaninfectious vaccinia virus recombinant thatexpresses theinfluenza hemagglutinin gene andinduces resistance toinfluenza virus infection inhamsters (1983) (0)
DNA immunisation of mice with Plasmodium berghei antigens: Use of whole antigens or multi-epitope strings, boosting with vaccinia and protection against challenge (1997) (0)
DNA followed by recombinant Vaccinia induces cellular and humoral immune responses against a pre-erythrocytic antigen of Plasmodium falciparum in chimpanzees (1997) (0)
Small-Scale High Temperature Melter-1 (SSHTM-1) Data Package (1996) (0)
The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunity (2022) (0)
Methods and reagents for production of a CD8 + T cell immune response against Melanoma (1998) (0)
DO VACCINIA VIRUS-ENCODED SERPINS INHIBIT ANTIGEN PRESENTATION TO CLASS I-RESTRICTED CTL (1993) (0)
Golgi anti-apoptotic proteins are evolutionarily conserved ion channels that regulate cell death in plants (2019) (0)
Esposito ( Smallpox ) Virus Genome Sequence Diversity and Clues to the Evolution of Variola (2014) (0)
Evaluation of high-level waste vitrification feed preparation chemistry for an NCAW simulant, FY 1994: Alternate flowsheets (DRAFT) (1996) (0)
Genus Orthopoxvirus : Vaccinia virus Summary (2019) (0)
CS09-5. DNA-dependent protein kinase is a DNA sensor for IRF-3-dependent innate immunity (2011) (0)
Refinery savings with the Amine Guard ST system (1986) (0)
Poxvirus strategies to prevent apoptosis of infected cells (1999) (0)
Immune Molecular Plasticity Links Viral Virulence to Protective T cell Vaccines (137.2) (2010) (0)
NUSAR: N Reactor Updated Safety Analysis Report, Amendment 21 (1989) (0)
- J9L: J9L PK (African swine fever virus) (1995) (0)
Structure of A49 from Vaccinia Virus Western Reserve (2015) (0)
Vaccinia virus B 5 protein affects the glycosylation , localization and stability of the A 34 protein (2010) (0)
Molecular mimicry of NF-κB by vaccinia virus protein enables selective inhibition of antiviral responses (2021) (0)
Enhanced immunogenicity for CTL induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara encoding pre-erythrocytic (1997) (0)
SCAD (Avian Diseases) II (2011) (0)
POXVIRUS CHEMOKINE-BINDING PROTEINS (1999) (0)
Study of vaccinia virus binding and entry using confocal microscopy, an original approach (1998) (0)
Two centuries of vaccination (1997) (0)
Vaccinia virus BTB-Kelch proteins C2 and F3 inhibit NF-κB activation. (2022) (0)
T Lymphocytes + to Recognition by CD8 Caspases in Virus-Infected Cells Contribute (0)
8-Specific Cytotoxic T-Cell Responses Identification of Human Herpesvirus (2013) (0)
Isolation of cell populations and staining for flow cytometry (2019) (0)
[Rapid cell-to-cell spread: a story of jumping viruses]. (2010) (0)
Small-Scale High Temperature Melter-1 (SSHTM-1) Data Package. Appendix A (1996) (0)
V accinia virus gene SalF 5 R is non-essential for virus replication in vitro and in vivo (2007) (0)
Smallpox vaccination induces a substantial increase in commensal skin bacteria that promote pathology and enhance immunity (2021) (0)
Structure of CrmE, a poxvirus TNF receptor (2007) (0)
Vaccinia Virus Inhibits NF- (cid:2) B-Dependent Gene Expression Downstream of p65 Translocation (2014) (0)
THE STRUCTURE OF VACCINIA VIRUS N1 Q61Y MUTANT (2012) (0)
The SARS-CoV-2 protein ORF3c is a mitochondrial modulator of innate immunity AUTHORS (2022) (0)
A49 binding to β-TrCP WD40 domain requires its N-terminal region. (2013) (0)
Enhancement of CD 8 + T-cell memory by removal of a vaccinia virus NF-κ B inhibitor Short title : Enhancing CD 8 + T-cell immunity (2014) (0)
vΔ169 generates better protection after challenge. (2015) (0)
Inhibitors of Innate Immunity from Vaccinia Virus (2010) (0)
Regimen Vaccinia Virus Ankara Boost Vaccination Multiepitope Gene and DNA Prime-Modified T Lymphocytes in Macaques by Using a Immunodeficiency Virus-Specific Cytotoxic Effective Induction of Simian (1999) (0)
6. Conclusions 7. References (0)
DDX50 is a viral restriction factor that enhances TRIF-dependent IRF3 activation (2020) (0)
Mechanisms of immune modulation by vaccinia virus protein C16 (2014) (0)
Structure of Vaccinia virus protein A52 (2008) (0)
Development of a CTL inducing vaccine against plasmodium falciparum using a combination of delivery systems (1998) (0)
Vaccinia virus strain modified virus Ankara: Characterisation of cytokine receptor profile, virological features, and use as an immunological reagent (1997) (0)
Cytotoxic t cell recognition of influenza virus gene products (1985) (0)
Nucleic Acids Research Transcriptional mapping and nucleotide sequence of a vaccinia virus gene encoding a polypeptide with extensive horaology to DNA ligases (2005) (0)
Heteroepitaxial Growth of ImP and GaInAs on GaAs Substrates Using Tertiarybutylarsine and Tertiarybutylphosphine (1990) (0)
VACCINES FOR SMALLPOX. AUTHOR'S REPLY (1999) (0)
Production andcharacterisation ofamonoclonal antibody tohumanpapillomavirus type16using recombinantvacciniavirus (1990) (0)
Protein 169 affects VACV virulence and immunogenicity in the intradermal model of infection. (2015) (0)
S190 Intracellular inhibitors of innate immunity encoded by Vaccinia virus (2007) (0)
RETRAN analysis of the N reactor (1982) (0)
Smallpox in the Post-Eradication EraHermann Meyer1 (2020) (0)
Vaceinia virus serpins B 13 R and B 22 R do not inhibit antigen presentation to class I-restricted cytotoxic T lymphocytes (2007) (0)
Research with variola virus after smallpox eradication: Development of a mouse model for variola virus infection (2021) (0)
A process for the preparation of poxvirus recombinant for the expression of foreign genes. (1983) (0)
CS18-3. Modulation of apoptosis and pro-inflammatory signalling by vaccinia virus protein N1 (2011) (0)
Methods and reagents for production of a CD8 + T cell immune response to hepatitis B or C (1998) (0)
The actin nucleator Spir-1 is a virus restriction factor that promotes IRF3 activation (2020) (0)
P.4.01.21 perspective of vaccine1 prophylaxis of pyoseptic complications (1997) (0)

This paper list is powered by the following services:

Other Resources About Geoffrey L. Smith

en.wikipedia.org

What Schools Are Affiliated With Geoffrey L. Smith?

Geoffrey L. Smith is affiliated with the following schools: